September 2016
Volume 57, Issue 12
Open Access
ARVO Annual Meeting Abstract  |   September 2016
Integrin alpha 9 blockade promotes corneal transplant survival
Gyeong Jin Kang; Tan Ngoc Truong; Eric Huang; Valerie Su; ShaoKui Ge; Lu Chen
Author Affiliations & Notes
  • Gyeong Jin Kang
    Vision Science Graduate Group, University of California, Berkeley, California, United States
    Center for Eye Disease and Development, Program in Vision Science and School of Optometry, University of California, Berkeley, California, United States
  • Tan Ngoc Truong
    Vision Science Graduate Group, University of California, Berkeley, California, United States
    Center for Eye Disease and Development, Program in Vision Science and School of Optometry, University of California, Berkeley, California, United States
  • Eric Huang
    Vision Science Graduate Group, University of California, Berkeley, California, United States
    Center for Eye Disease and Development, Program in Vision Science and School of Optometry, University of California, Berkeley, California, United States
  • Valerie Su
    Vision Science Graduate Group, University of California, Berkeley, California, United States
    Center for Eye Disease and Development, Program in Vision Science and School of Optometry, University of California, Berkeley, California, United States
  • ShaoKui Ge
    Vision Science Graduate Group, University of California, Berkeley, California, United States
    Center for Eye Disease and Development, Program in Vision Science and School of Optometry, University of California, Berkeley, California, United States
  • Lu Chen
    Vision Science Graduate Group, University of California, Berkeley, California, United States
    Center for Eye Disease and Development, Program in Vision Science and School of Optometry, University of California, Berkeley, California, United States
  • Footnotes
    Commercial Relationships   Gyeong Jin Kang, None; Tan Truong, None; Eric Huang, None; Valerie Su, None; ShaoKui Ge, None; Lu Chen, None
  • Footnotes
    Support  NIH and University of California at Berkeley (LC)
Investigative Ophthalmology & Visual Science September 2016, Vol.57, 1446. doi:
  • Views
  • Share
  • Tools
    • Alerts
      User Alerts
      You are adding an alert for:
      Integrin alpha 9 blockade promotes corneal transplant survival
      You will receive an email whenever this article is corrected, updated, or cited in the literature. You can manage this and all other alerts in My Account
      The alert will be sent to:
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation
      Citation

      Gyeong Jin Kang, Tan Ngoc Truong, Eric Huang, Valerie Su, ShaoKui Ge, Lu Chen; Integrin alpha 9 blockade promotes corneal transplant survival. Invest. Ophthalmol. Vis. Sci. 2016;57(12):1446.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

      ×
    • Get Permissions
  • Supplements
Abstract

Purpose : The lymphatic pathway mediates corneal transplant rejection. We recently reported that corneal lymphatic vessels develop luminal valves as lymphangiogenesis proceeds. These valves express integrin alpha 9 (Itga-9) and play a critical role in directing lymph flow. This study was designed to investigate the effect of Itga-9 blockade on corneal transplant rejection.

Methods : Orthotopic corneal transplantation was performed between C57BL/6 (donor) and BALB/c (recipient) mice. The recipients were randomized to receive subconjunctival injections of either Itga-9 blocking antibody (kindly provided by Dr. Toshimitsu Uede, Hokkaido University) or isotype control twice a week for 8 weeks. Corneal grafts were evaluated by ophthalmic slit-lamp biomicroscopy and analyzed by Kaplan-Meier survival curve.

Results : While Itga-9 blockade reduced lymphatic valvulogenesis associated with transplantation, this treatment promoted corneal graft survival, compared to the control condition.

Conclusions : Itga-9 is involved in corneal transplant rejection. Further study on this pathway may provide novel strategies to modulate lymphatic valvulogenesis and graft rejection.

This is an abstract that was submitted for the 2016 ARVO Annual Meeting, held in Seattle, Wash., May 1-5, 2016.

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Attribution-NonCommercial-NoDerivatives
Copyright © 2024 Association for Research in Vision and Ophthalmology.
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×
This site uses cookies. By continuing to use our website, you are agreeing to our privacy policy.Accept